TARA R&D Expense Growth
Protara Therapeutics Inc · R&D Expense Growth
TARA R&D Expense Growth
Latest reported34.47%period ending
TARA FY R&D Growth (YoY) (0.00% → 34.47%)
Latest values, visible window
High-resolution chart · PNG
TARA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 34.472% | |
| 27.9161% | |
| 47.4595% | |
| -20.2959% | |
| 77.4636% | |
| 84.576% | |
| -58.4806% | |
| -28.4976% | |
| 14.9292% | |
| 52.4029% | |
| 92.4907% | |
| 61.0416% | |
| -32.3853% | |
| 0% |